US FDA | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
January 03, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, JANUARY 03, 2026

US FDA

US FDA

Photo: Collected

US FDA approves new glasses that slow near-sightedness in children

The FDA-approved Essilor Stellest lenses are designed for 6 to 12-year-olds and use 11 concentric rings with raised dots to redirect light onto the retina, slowing eye elongation

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

US FDA asks fired scientists to return, including some reviewing Musk's Neuralink

Raja Krishnamoorthi (D-IL), Ranking Member of the House Select Committee on Strategic Competition between the United States and the Chinese Communist Party asks a question in Boston, Massachusetts, US, February 12, 2024. Photo: REUTERS/Reba Saldanha/File Photo

US clinical trials in China questioned by US lawmakers

Acme's muscle relaxant tablet 'Chlorzoxazone 500' gets US FDA approval

Acme's muscle relaxant tablet 'Chlorzoxazone 500' gets US FDA approval

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

US FDA says India-made eye drop linked to some infections, blindness and one death

A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. Photo: Reuters

US FDA authorizes Novavax Covid vaccine for adults

Photo: Collected

US approves first pill for treatment of alopecia

FILE PHOTO: An employee shows the Moderna coronavirus disease (Covid-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, US, December 21, 2020. REUTERS/Eduardo Munoz

US CDC backs full approval of Moderna's Covid-19 vaccine

Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021.  Photo :Reuters

US FDA set to authorize Pfizer, Merck Covid-19 pills this week - Bloomberg News

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed

US FDA lifts clinical hold on Inovio's Covid-19 vaccine trial

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo

US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

US FDA gives marketing nod to an e-cigarette for the first time

Syringes filled with a dose of the Moderna Covid-19 vaccine sit on a table during an employee vaccination at the Sarasota Memorial Hospital in Sarasota, Florida, US, September 24, 2021. Photo :Reuters

US FDA staff says Moderna did not meet all criteria for Covid-19 boosters

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net